Strategy using genetically engineered T cells would attack cancer while sparing healthy blood stem cells.
Two-pronged immunotherapy approach could treat most blood cancers
Posted in biotech/medical, genetics
Posted in biotech/medical, genetics
Strategy using genetically engineered T cells would attack cancer while sparing healthy blood stem cells.